Musculo-skeletal System

Published on 30/06/2015 by admin

Filed under Pathology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1823 times

Chapter 15 Musculo-Skeletal System

Osteoporosis

OSTEOPOROSIS is the commonest disorder of bone. It is defined as a systemic disease characterised by:

A patient is said to have osteoporosis if bone mineral density >2.5 standard deviations below the mean of normal young subjects.

Clinical effects: – osteoporosis is a disease predominantly of post-menopausal females, but men are also affected.

Note: In osteoporosis, the routine serum biochemical tests – particularly the calcium levels – are within the normal range.

Pathology: The changes in the vertebral bodies are shown.

Note:

Infections of Bone

Developmental Abnormalities

Generalised abnormalities are rare and usually inherited.

Tumours in Bone

Primary bone tumours are rare. There are both benign and malignant forms, examples of which follow. In contrast, metastatic tumours and myeloma are common.

Malignant Tumours

Primary malignant tumours of bone are not common, but they are important as many arise in young people and are highly malignant. Some arise in older people with pre-existing bone disorders, e.g. Paget’s disease, previous irradiation.

Lymphoid Tumours

Lymphoma and myeloma (see p.435) may arise in bone, causing bone destruction.

Osteoarthritis (OA)

Osteoarthritis (OA)

This is the commonest disorder of joints and, by causing pain and stiffness, is the commonest cause of chronic disability after middle age. The basic pathology is degenerative and is similar to the changes of ageing.

The disorder is divided into two main groups. In both types of osteoarthritis the basic pathological processes are the same.

The integrity of the articular cartilage represents a balance between ‘wear and tear’ losses and replacement by chondrocytes of the specialised matrix.

The earliest change in ageing and OA is in the chemical composition of the matrix which becomes softer. This is followed by progressive characteristic morphological changes.

The synovial membrane may show mild, non-specific inflammation and effusion may occur but these changes are secondary.

Distribution: secondary OA often affects a single predisposed joint.

In primary OA, the larger weight bearing joints and the spine in particular are susceptible, but interphalangeal joints bear osteophytic outgrowths (Heberden’s and Bouchard’s nodes). Osteoarthritis is the main indication for hip and knee replacement surgery.

A particularly severe form (Charcot’s joint) is seen when the nerve supply to a joint is defective – neuropathic arthropathy.

Rheumatoid Arthritis (RA)

Rheumatoid arthritis (RA) is a common systemic disease (1–3% of population in Europe). The most affected tissue is the synovial membrane. The typical clinical course is insidious in its onset and progression; in a minority, the onset is acute and the progress rapid. Frequently there are remissions and exacerbations.

Incidence: female > male 3:1 Age of onset: usually 35–55 years, but also in childhood – usually severe.

Typically, affecting multiple joints symmetrically, the joints of the hands and feet and the knee joints are affected; there may be involvement of the spine.

Pathology: The synovial membrane shows chronic inflammation.

Sero-Negative Arthritis

Ankylosing spondylitis (AS) is an arthritis affecting particularly the sacroiliac, costovertebral and vertebral joints, but peripheral arthritis is also seen.

Incidence: 0.05% of population male:female; 3:1. Age of onset: Young adults progressing into middle age.
Rheumatoid factor negative.

The disorder is, like RA, an active chronic arthritis, but differs in that it may cause osseous ankylosis (bony union), so that no movement of the affected joints is possible.

Aortitis leading to aortic incompetence and uveitis may be seen.

Psoriatic arthritis affects the axial and peripheral joints. Typically the distal interphalangeal joints are involved and the adjacent nails are affected.

Reiter’s syndrome: This is a syndrome of polyarthritis, urethritis and uveitis following infections, e.g. chlamydia, yersinia and salmonella. The detailed mechanisms are unclear.

HLA association. Ankylosing spondylitis, psoriatic arthritis and Reiter’s syndrome are associated with HLA-B27 (>95% in AS). Genetic susceptibility is an important factor predisposing to the arthritis.

No such association with HLA-B27 is evident with RA, which however shows an association with HLA-DR4, twice that of the general population.

  OSTEOARTHRITIS RHEUMATOID ARTHRITIS
Type of disorder Degenerative Inflammatory
Site of initial damage Articular cartilage Synovial membrane
Age Late middle age + 3rd decade (any age)
Joints affected Large weight bearing often single, pre-existing local factors in some cases Small joints of hands and feet, multiple
Systemic disease None
ESR – normal
Rheumatoid factor – absent
++
ESR ↑
Rheumatoid factor positive
Secondary anaemia

Collagen Diseases

This term describes a group of multisystem diseases, many autoimmune in origin.

The group includes rheumatoid arthritis (RA); systemic lupus erythematosus (SLE); systemic sclerosis; polyarteritis nodosa (PAN) and dermatomyositis.

Inherited Myopathies

Specific Metabolic Defects

There is a group of genetic myopathies with specific biochemical or morphological abnormalities.

In some, the inborn error of metabolism is generalised and includes muscle; in others it is confined to the muscle fibre. Some examples will be given:

(1) Glycogen storage (2) Lipid metabolism (3) Periodic paralysis
Type 2 (Pompe) – deficiency of acid maltase
Type 5 (McArdle) – muscle phosphorylase
Type 7 – phosphofructokinase (PFK)
Defect in free fatty acid transport into and utilisation within fibre.

Associated with hypo-and hyperkalaemia – the muscle defect is a vacuolar degeneration of the sarcolemma (4) Morphological abnormalities (a) Mitochondrial (b) Others Large or increased numbers of mitochondria – abnormal oxidative processes (i) Central core myopathy image (iii) Centronuclear myopathy image (ii) Rod body myopathy (nemaline) image (iv) Disproportion of fibre types I and II

These myopathies vary in age of onset, clinical presentation and prognosis.

A further rare but interesting autosomal dominant genetic abnormality of muscle is malignant hyperpyrexia. In this condition the administration of a general anaesthetic precipitates acute muscle damage. Clinically, there is very high fever, muscle stiffness, cyanosis and acidosis very often resulting in death.

Muscle Diseases – Diagnosis

Accurate diagnosis of muscular weakness and atrophy is important since there is considerable variation in prognosis and management of these disorders, although often there is no treatment.

A diagnosis is usually reached from a synthesis of the information obtained from investigations under three headings: